During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
Johnson & Johnson (NYSE:JNJ)
- Dividend Yield: 3.16%
- Barclays analyst Matt Miksic maintained an Equal-Weight rating and raised the price target from $165 to $176 on July 17, 2025. This analyst has an accuracy rate of 65%.
- Guggenheim analyst Vamil Divan maintained a Neutral rating and boosted the price target from $164 to $167 on July 17, 2025. This analyst has an accuracy rate of 75%.
- Recent News: …
Full story available on Benzinga.com
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
Johnson & Johnson (NYSE:JNJ)
- Dividend Yield: 3.16%
- Barclays analyst Matt Miksic maintained an Equal-Weight rating and raised the price target from $165 to $176 on July 17, 2025. This analyst has an accuracy rate of 65%.
- Guggenheim analyst Vamil Divan maintained a Neutral rating and boosted the price target from $164 to $167 on July 17, 2025. This analyst has an accuracy rate of 75%.
- Recent News: …
Full story available on Benzinga.com
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
Johnson & Johnson (NYSE:JNJ)
Dividend Yield: 3.16%
Barclays analyst Matt Miksic maintained an Equal-Weight rating and raised the price target from $165 to $176 on July 17, 2025. This analyst has an accuracy rate of 65%.
Guggenheim analyst Vamil Divan maintained a Neutral rating and boosted the price target from $164 to $167 on July 17, 2025. This analyst has an accuracy rate of 75%.
Recent News: …Full story available on Benzinga.com Read MoreBAX, dividend yield, Expert Ideas, JNJ, Long Ideas, MDT, News, Wall Street’s Most Accurate Analysts, Dividends, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, BAX, US0718131099, JNJ, US4781601046, MDT, US5850551061, Long Ideas, News, Dividends, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
